Form 4: ACMR CEO David Wang Exercises Options, Sells Shares

ACM Research CEO David H. Wang executed pre-planned transactions, exercising stock options and selling a portion of his Class A Common Stock holdings.

Summary

• David H. Wang, CEO, President, Director, and 10% Owner of ACM Research, Inc. (ACMR), engaged in pre-scheduled transactions on March 11 and March 12, 2026.
• On March 11, 2026, Wang exercised options to acquire 60,000 shares of Class A Common Stock at an exercise price of $1.00 per share.
• Concurrently on March 11, 2026, he sold a total of 60,000 shares of Class A Common Stock at weighted average prices of $47.89 and $48.34 per share.
• On March 12, 2026, Wang exercised options to acquire 50,000 shares of Class A Common Stock at an exercise price of $1.00 per share.
• Concurrently on March 12, 2026, he sold a total of 49,000 shares of Class A Common Stock at weighted average prices of $44.92, $45.74, and $46.57 per share.
• All sales were conducted under a Rule 10b5-1 trading plan adopted on November 29, 2024.
• Following these transactions, Wang directly beneficially owns 802,708 shares of Class A Common Stock and indirectly owns 945,840 shares through family members and trusts.
• His direct beneficial ownership of derivative securities (stock options) decreased from 480,002 to 370,002 after these exercises.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While insider selling can sometimes be a negative signal, the execution under a pre-arranged 10b5-1 plan mitigates concerns that it's based on new adverse information. It's a routine part of executive compensation management.

Positives

• The exercise of stock options at a low price of $1.00 indicates a significant in-the-money value for the options.
• The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, indicating a systematic approach to managing equity holdings rather than a reaction to immediate company news.

Negatives

• David H. Wang sold a total of 109,000 shares of Class A Common Stock over two days.
• The sales occurred at weighted average prices ranging from $44.92 to $48.34, which could be perceived as management taking profits.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transactions, particularly sales, are closely watched by investors for signals regarding management's perception of future company performance. While these sales were pre-planned under a 10b5-1 plan, they represent a significant monetization of equity by a key executive in the semiconductor equipment industry.

Related Party Transactions

• David H. Wang's indirect beneficial ownership includes shares held by his wife, Jing Chen (100,002 shares), his daughter, Sophia Wang (45,837 shares), the David Hui Wang and Jing Chen Family Irrevocable Trust for Wang Children (180,000 shares), and the Wang-Chen Family Living Trust (620,001 shares).

Stakeholder Impact

• Shareholders may interpret the sales by a key executive as a signal, though the 10b5-1 plan suggests a planned diversification rather than a lack of confidence.
• Employees might observe executive share sales as part of compensation management.

Key Dates

Recommendation

The transactions are routine insider sales executed under a pre-planned 10b5-1 program, which typically reduces the negative signaling effect compared to unplanned sales. While a significant number of shares were sold, the underlying business fundamentals of ACM Research are not directly addressed by this filing. Investors should hold and evaluate the company based on its operational performance and future guidance rather than solely on these pre-scheduled insider transactions.

Keywords

ACM Research, ACMR, David H. Wang, Insider Trading, Form 4, Stock Options, Share Sale, 10b5-1 Plan, CEO, Director, 10% Owner, Semiconductor Equipment